Control of Influenza

Texas Heart Institute Journal

Volumn 31, Issue 1, 2004, Pages 39-41

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Immunization; Influenza A virus; Influenza vaccine immunology; Influenza complications epidemiology prevention control; United States epidemiology; Vaccine, intranasal; Vaccines, attenuated

Indexed keywords

INFLUENZA VACCINE;

COMMUNITY; CONFERENCE PAPER; DRUG COST; DRUG DELIVERY SYSTEM; HIGH RISK POPULATION; HUMAN; IMMUNOPROPHYLAXIS; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MORTALITY; NONHUMAN; SCHOOL; SIDE EFFECT; WORK;

ADMINISTRATION, INHALATION; ANTIBODIES, VIRAL; COMMUNITY HEALTH SERVICES; CRYOPRESERVATION; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RISK FACTORS; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 1642365008     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
2. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA; Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum appears in MMWR Morb Mortal Wkly Rep 2003;52:526]. MMWR Recomm Rep 2003;52(RR-8):1-34.
3. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA; Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum appears in MMWR Morb Mortal Wkly Rep 2003;52:526]. MMWR Recomm Rep 2003;52(RR-8):1-34.
4. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
6. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J 1997;16:1065-8.
7. Neuzil KM, Hohlbein C, Zhu Y. Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med 2002;156:986-91.
8. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.
9. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-505.
10. Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001;138:306-10.
11. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SE Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000;30:784-9.
12. Robinson P, Taylor K, Nolan T. Risk-factors for meningococcal disease in Victoria, Australia, in 1997. Epidemiol Infect 2001;127:261-8.
13. Bernstein T, Brilli R, Jacobs B. Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis 1998;27:458-62.
14. Glezen WP. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 2000; 19 Suppl 1:S56-8.
15. Glezen WP. Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980; 2:408-20.
16. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18:64-76.
17. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333:889-93.
18. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999;282:137-44.
19. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness of cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000;284:1655-63.
20. Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003;21:2216-26.
21. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970;122:16-25.
22. Reichert TA, Sugaya N, Fedson, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001;344:889-96.
23. Piedra PA, Gaglani MJ, Herschler G, Riggs M, Griffith M, Kozinetz C, Glezen WP. Safety and effectiveness of trivalent, cold-adapted influenza virus vaccine (CAIV-T) in children. In: Osterhaus AD, Hampson AW, Cox N, editors. Options for the control of influenza IV. Proceedings of the World Congress on Options for the control of Influenza IV; 2000 September 23-28; Crete, Greece. Amsterdam: Exerpta Medica; 2001. p. 939-43.
24. Halloran ME, Longini IM Jr, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol 2003;158:305-11.
25. Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA, Riggs MW, et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 2004;158:65-73.